Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Metformin (850mg) + Vildagliptin (50mg) Tablet
Therapeutic Category
Antidiabetic, Cardiology, Diabetic
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Vlidaplit M 850 Tablet containing Metformin and Vildagliptin is used for the management of type 2 diabetes mellitus. It helps improve glycemic control and supports long-term diabetes management when used alongside appropriate lifestyle modifications.
Metformin helps reduce hepatic glucose production and improves insulin sensitivity, while Vildagliptin works as a DPP-4 inhibitor that enhances the body's natural incretin activity to support better blood glucose regulation.
The tablet is widely prescribed in diabetology and general medicine practice for patients requiring combination therapy for effective blood sugar management, leading to consistent prescription demand.
With the increasing prevalence of diabetes and growing demand for advanced anti-diabetic therapies, this product offers strong business potential for retailers and distributors. Its combination formulation, established clinical efficacy, and steady market demand make it a reliable product for growth in the anti-diabetic segment.
Some patients may experience nausea, vomiting, diarrhea, abdominal discomfort, loss of appetite, headache, dizziness, or weakness. Rarely, pancreatitis, severe allergic reactions, liver function abnormalities, or lactic acidosis associated with Metformin may occur and require immediate medical attention.
Vlidaplit M 850 Tablet is indicated for the management of Type 2 Diabetes Mellitus in adults when diet, exercise, and single-drug therapy do not provide adequate blood glucose control. It helps lower fasting and postprandial blood sugar levels and supports long-term diabetes management.
This medicine should be used strictly under medical supervision. Regular monitoring of blood glucose levels, kidney function, and liver function is recommended during treatment. Use cautiously in patients with kidney disease, liver impairment, heart failure, or conditions that increase the risk of lactic acidosis. Maintain a healthy diet and regular exercise program alongside medication for optimal diabetes control.
Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.
Composition : Atorvastatin 10mg + Aspirin 75mg + Clopidogrel 75mg Capsule
Composition : Atorvastatin (10mg) + Aspirin (75mg) Capsule
Composition : Atorvastatin Calcium I.P. 20mg + Clopidogrel I.P. 75mg + Aspirin I.P. 75mg Capsules
Composition : Atorvastatin Calcium I.P. 10mg + Clopidogrel I.P. 75mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Aspirin I.P. 75mg Capsules
Composition : Atorvastatin Calcium I.P. 80mg Tablets
Composition : Atorvastatin Calcium I.P. 40mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg Tablets
Composition : Atorvastatin Calcium I.P. 20mg Tablets
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Metformin 850mg + Vildagliptin 50mg Tablet has strong demand in the diabetology, endocrinology, and chronic care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on anti-diabetic and lifestyle disease management portfolios.
Medical distributors and agencies can benefit from consistent demand for Type 2 Diabetes Mellitus management under medical supervision. Metformin 850mg helps improve insulin sensitivity and reduce glucose production by the liver Vildagliptin 50mg is a DPP-4 inhibitor that helps improve blood glucose control by enhancing incretin hormone activity Commonly prescribed for Type 2 Diabetes Mellitus when diet, exercise, and single-drug therapy are insufficient Provides complementary mechanisms for effective glycemic control Widely prescribed by diabetologists, endocrinologists, and general physicians This strengthens a comprehensive anti-diabetic and chronic care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Metformin 850mg + Vildagliptin 50mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong prescription demand, long-term therapy usage, repeat monthly purchases, reliable supply chain support, and attractive margins in the anti-diabetic segment.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.